Literature DB >> 15052582

Determination of cefuroxime in human serum or plasma by liquid chromatography with electrospray tandem mass spectrometry.

Anders Viberg1, Marie Sandström, Britt Jansson.   

Abstract

Cefuroxime is a second-generation cephalosporin used against different kinds of bacterial infections. To be able to optimize the dosing it is necessary to characterize the pharmacokinetics of cefuroxime which requires a selective and sensitive analytical method for cefuroxime in plasma or serum. A new rapid liquid chromatography/electrospray tandem mass spectrometry (LC/MS/MS) method, using cefotaxime as internal standard, was developed for analysis of cefuroxime in human serum. The work-up procedure consisted of protein precipitation with acetonitrile/cefotaxime, and after centrifugation the supernatant was dissolved in mobile phase. The sample was injected on a SB-CN column and the detection was performed using tandem mass spectrometry (MS/MS). The limit of quantification was determined to 0.025 microg/mL. The method was linear in the range 0.025-50 microg/mL with a coefficient of correlation >0.999. The limit of quantification and intra-day variability were found to be the same for plasma samples, which indicates that the method is valid for serum as well as plasma samples. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052582     DOI: 10.1002/rcm.1396

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  4 in total

1.  A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Authors:  Anders Viberg; Anders Lannergård; Anders Larsson; Otto Cars; Mats O Karlsson; Marie Sandström
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

2.  Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.

Authors:  Long-shan Zhao; Ran Yin; Bin-bin Wei; Qing Li; Zhen-yuan Jiang; Xiao-hui Chen; Kai-shun Bi
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

3.  Simple and Robust Analysis of Cefuroxime in Human Plasma by LC-MS/MS: Application to a Bioequivalence Study.

Authors:  Xingjiang Hu; Mingzhu Huang; Jian Liu; Junchun Chen; Jianzhong Shentu
Journal:  Adv Pharmacol Sci       Date:  2014-04-24

4.  Quantification of total and unbound cefuroxime in plasma by ultra-performance liquid chromatography tandem mass spectrometry in a cohort of critically ill patients with hypoalbuminemia and renal failure.

Authors:  Joost J van Raaij; Noortje J D Mabelis; Kimberly N Shudofsky; Sjoerd D Meenks; Jos L M L le Noble; Paddy K C Janssen
Journal:  J Clin Lab Anal       Date:  2019-11-30       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.